Intuitive Surgical, Inc. (ISRG)

Ion Platform Poised for Cost Optimization: A Margin Lever for ISRG?

Intuitive Surgical's Ion platform is driving rapid growth, but cost optimization could be the key to turning it from a margin drag to a margin lever.

MemorialCare Launches Da Vinci 5 Robotic Surgical System, Expanding Robotic Surgical Program Access Across All Hospitals in Health System

Next-generation technology enhances precision, improves patient outcomes, and expands minimally invasive surgery across Long Beach, Fountain Valley and Laguna Hills. FOUNTAIN VALLEY, Calif.

Intuitive Surgical: What's Happening With ISRG Stock?

Intuitive Surgical stock (NASDAQ: ISRG) has dropped 16% this year, notably lagging behind the S&P 500's 10% increase. The stock has experienced downward pressure recently after management indicated that potential tariffs may adversely affect its performance in 2026.

Intuitive Surgical, Inc. (ISRG) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Intuitive Surgical, Inc. (NASDAQ:ISRG ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 9:30 AM EDT Company Participants David Rosa - CEO & Director Jamie Samath - CFO, Head of Business Technology & Enterprise Technology Leader Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst All right. Good morning, everyone.

The Best Home Run Growth Stocks To Buy Today

ISRG's SP Stapler: A Game Changer for Colorectal and Thoracic Procedures?

Intuitive Surgical's new SP stapler opens doors to colorectal and thoracic surgeries, potentially transforming the single-port platform's adoption curve.

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

ISRG vs. MDT: Which MedTech Titan Is the Stronger Investment Choice Now?

ISRG's strong double-digit robotic growth stands in contrast to MDT's diversified portfolio and more attractive valuation, setting up a compelling medtech comparison.

SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?

Intuitive Surgical's SP platform posts 88% procedure growth in Q2, driven by a 112% surge in Korea and expanding adoption in colorectal and thoracic surgery.

Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

ISRG's International Push for Ion: Strategic Bet or Overstretch?

Intuitive Surgical expands Ion into Australia and Korea after 52% procedure growth, testing Asia-Pacific adoption despite budget headwinds.

ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?

Intuitive Surgical's Ion platform saw Q2 procedures jump 52% to 35,000, expanding globally as utilization rises despite softer system placements.

ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story

Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.

Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock

Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Cathie Wood Goes Shopping: 3 Stocks She Just Bought

Cathie Wood is built for rallying markets. The co-founder, CEO, and chief investment officer of Ark Invest is crushing the market this year, proving that she can catch 2020 in a bottle again.

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

ISRG's Gross Margin Falls on Product Transition and Trade Pressures

Intuitive Surgical's Q2 gross margin declines to 67.9% as product mix shifts, new facility costs and tariffs weigh on profitability.

Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?

ISRG's Q2 procedure growth hits 17%, but continuation of EPS growth hinges on easing margin pressure from FX and da Vinci 5 adoption.

Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Intuitive Surgical Crushes Q2 Expectations, So Why No Rally?

The world's second-largest company in the healthcare equipment and supplies industry, Intuitive Surgical NASDAQ: ISRG, just reported Q2 financials. The results were solid, but not enough to move shares higher.

ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts

Intuitive Surgical's second-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.

Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade)

Intuitive Surgical's premium valuation is justified by consistent mid-teens growth, a dominant market position, and a resilient razor-and-blade business model. Recent innovations like telesurgery and regulatory approvals further expand the company's total addressable market and reinforce its competitive moat. Risks include potential tariff impacts and capital return missteps, but a strong balance sheet and recurring revenues mitigate these concerns.

ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval

Intuitive Surgical wins FDA nod for its Vessel Sealer Curved, boosting the da Vinci system's precision and multifunctional capabilities.

Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

Hospital Capex Headwind: Temporary Setback or Lasting Risk for ISRG?

Intuitive Surgical's global da Vinci growth faces resistance as hospital CapEx tightens abroad, testing leasing and utilization strategies.

Vessel Sealer Curved receives FDA clearance

Intuitive's latest advanced energy instrument features a unique curved tip for enhanced precision Intuitive's latest advanced energy instrument features a unique curved tip for enhanced precision

ISRG Expands Installed Base, But Is Utilization Keeping Pace?

Intuitive Surgical's installed base tops 10,000, but flat utilization growth raises questions about ROI and system productivity.

ISRG da Vinci 5 Gets European Nod: Will it Boost the Stock's Prospect?

ISRG's da Vinci 5 wins CE mark, unlocking Europe's surgical robotics market as U.S. adoption shows strong early traction.

Intuitive Surgical's Fifth Generation da Vinci System Receives CE Mark

ISRG secures CE mark for its da Vinci 5 system, unlocking European access to its most advanced surgical platform yet.